Results 61 to 70 of about 166,449,558 (233)

Tumor-induced myeloid cell plasticity toward lymphatic endothelium [PDF]

, 2009
Tumor-associated lymphangiogenesis contributes to tumor progression by regulating interstitial fluid pressure, transporting immune cells to the tumor site and providing a route for metastatic dissemination.
Baeriswyl, Vanessa
core   +1 more source

Adaptive Immunity in Marsupials

Journal of Experimental Zoology Part A: Ecological and Integrative Physiology, EarlyView.
Comparison of the marsupial and eutherian adaptive immune systems. ABSTRACT Marsupials diverged from eutherian mammals 125–160 million years ago. Although evolutionarily distinct, both groups of mammals can produce complex adaptive immune responses to antigens with several key differences.
Cassandra L. Jol, Hayley J. Stannard, Julie M. Old   +2 more
wiley   +1 more source

Giant Cell Tumor of the Tendon Sheath Causing Tarsal Tunnel Syndrome : A Case Report

, 2012
Tarsal tunnel syndrome is defined as a compressive neuropathy of posterior tibial nerve and its branches, medial and lateral plantar nerves , within the tarsal tunnel, which is located in the limited space behind medial malleolus. Giant cell tumor of the
WANG, CHENG-WEI;CHEN, CHIH-YU;WU, KARL;YANG, RONG-SEN, 王政為;陳致宇;吳凱文;楊榮森   +1 more
core   +1 more source

Pulmonary Metastasis of Benign Giant Cell Tumor of Bone [PDF]

, 1994
Benign giant cell tumor of bone, despite being classified as benign, has the unusual ability to metastasize. Metastasis of such a tumor has been thought to be rare, with only approximately 50 such cases having been reported.
Eckardt, Jeffrey J, Kay, Robert M, Seeger, Leanne L, Mirra, Joseph M, Hak, David J   +4 more
core   +1 more source

Intraoperative Evaluation of Sarcoma Surgical Margins With Indocyanine Green Fluorescence Imaging: Results From an Observational Study

Journal of Surgical Oncology, EarlyView.
ABSTRACT Introduction Sarcomas are rare malignancies that affect both adults and children. Surgical removal with negative histopathological margins is the foundation of sarcoma treatment. Failure to achieve negative margins puts patients at risk of local recurrence (LR). LR rates range between 10% and 30%.
Sumail Bhogal, Matthew Gong, William Li, Brenda Diergaarde, Alma Heyl, Clark Roth, Lawrence Garvin II, Alexander Hoffman, Amanda Locker, Ines Lohse, Maria Silvaggio, Stella Lee, Richard McGough, Kurt Weiss   +13 more
wiley   +1 more source

Incidence Trends in the Diagnosis of Giant Cell Tumor of Bone in Sweden Since 1958.

, 2015
The Swedish Cancer Registry (founded in 1958) constitutes a unique resource for epidemiological studies of giant cell tumor of bone with potential for use for population-based studies of incidence over time.
Sobocki, Patrik, Rockberg, Julia, Amelio, Justyna, Hernandez, Rohini K, Engellau, Jacob,, Bach, Bruce A, Engellau, Jacob, Liede, Alexander, Bauer, Henrik C F, Lund University.   +9 more
core   +1 more source

Comparative electron microscopic and immunohistochemical study of stromal cells in giant cell tumor of bone [PDF]

, 2015
Giant cell tumor of bone is an osseous neoplasm that is histologically benign but clinically shows local aggression and high rate of recurrence. The histogenesis of this lesion remains unclear.
Slavchev, Svetoslav A.; Medical University of Sofia, Georgiev, Georgi P.; Medical University of Sofia, Malinova, Lina; Medical University of Sofia, Stokov, Luben; Medical University of Sofia, Landzhov, Boycho; Medical University of Sofia, Ovtscharoff, Wladimir; Medical University of Sofia, Rashev, Pavel; Medical University of Sofia, Todorov, Todor; Medical University of Sofia   +7 more
core   +1 more source

Giant Cell Tumor of the Rib

Eurasian Journal of Medicine, 2019
Giant cell tumors of the bone are approximately 5% of all bone neoplasms. They place around the epiphysis of long bones in 75-90% of patients following after skeletal maturity. Only 0.5-0.6% of the giant cell tumor are located in the rib.
Atila Türkyılmaz, Yener Aydın, Mine Çelik, Atilla Eroğlu   +3 more
doaj  

Significance of Biogenetic Markers in Giant Cell Tumor Differentiation and Prognosis: A Narrative Review

Diagnostics
Background: Giant cell tumor of bone (GCTB) is a locally aggressive tumor. It accounts for only 5% of all bony tumors. Early diagnosis, and follow-up for recurrence is often difficult due to a lack of biogenetic markers.
Muhammad Taqi, Haseeb ul Rasool, Mobeen Zaka Haider, Munjed Al Muderis   +3 more
doaj   +1 more source

Extended Curettage for Local Control of Chondromyxoid Fibroma: A 33‐Year Experience at a Single Tertiary Center

Journal of Surgical Oncology, EarlyView.
ABSTRACT Background and Objectives The management of chondromyxoid fibroma (CMF) primarily relies on surgical resection, but simple curettage is reportedly associated with a high local recurrence rate. While extended curettage with high‐speed burring effectively manages other locally aggressive bone tumors, its effectiveness for CMF remains unclear. We
Liuzhe Zhang, David Clever, Aaron M. Gazendam, Anthony M. Griffin, Kim Tsoi, Peter C. Ferguson, Jay S. Wunder   +6 more
wiley   +1 more source